Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

2013

Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome—positive acute lymphoblastic leukemia

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

13

References

35

Citations